November domestic paint patent courier (1)
Selection and use of amino acid columns.
Cell Death Dis: FBI-1 enhances resistance to triple-negative breast cancer through the miR-30c/PXR path.
PD-1 monoanti-Opdivo combined with TKI inhibitor Cabometyx to treat kidney cancer, which received FDA priority review.
Nat Commun: AP-1 and TGF beta co-mediate the resistance of non-classical Hedgehog signal transducting paths to induce substrate cell carcinoma.
Lancet Infect Dis: BBIBP-CorV New Coronary Pneumonia Inactivated Vaccine Phase 1/2 study was successful.
Kang Cai and Tai's net profit fell 33% in the first three quarters of Xianle Health's proposed debt issue of 1 billion yuan.
Colum took 1 billion varieties of Bayer 90% of the market dangerous.
Separation of proteins of different molecular weights - gel column layering method.
The concept of the stratography column and its principle of action.
Research and development daily Hengrui 1 new drug "phosphate reglitin tablets" reported the listing.
"Pharmaceutical Express" 14 batches of drugs are not qualified Johnson and Johnson new crown vaccine 1/2a clinical results.
Love pure pie . . . The laboratory column encyclodeda came.
Research and development daily Junshi bioPD-1 single anti-phase 3 clinical reached the main research endpoint.
1 generation of drug harm, 2 generations of drug king! Can the 3rd-generation drug "Pomadamine" surpass it?
5 new Class 1 drugs! 7 new products to attack the East China Sprint first imitation.
Kangfang bio-anti-PD-1 mono-anti-registered clinical up to the main end of the third-line treatment of nasopharyngeal cancer.
Deactivate insulin Reversal neJM rare case of type 1 diabetes suggests JAK inhibitor potential.
2020 Paint Industry No. 1 Introduction.
The application for the listing of a new class 1 drug for liver cancer is to be included in the priority review.